SUBSTITUTED PYRIDO[1,2-A]PYRAZINES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE AND/OR NEUROLOGICAL DISORDERS

Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed. La pré...

Full description

Saved in:
Bibliographic Details
Main Authors KAUFFMAN, GREGORY WAYNE, VERHOEST, PATRICK ROBERT, PETTERSSON, MARTIN YOUNGJIN, TRAN, TUAN PHONG, JOHNSON, DOUGLAS SCOTT, STIFF, CORY MICHAEL, AM ENDE, CHRISTOPHER WILLIAM, PATEL, NANDINI CHATURBHAI, SUBRAMANYAM, CHAKRAPANI, GREEN, MICHAEL ERIC, O'DONNELL, CHRISTOPHER JOHN, STEPAN, ANTONIA FRIEDERIKE
Format Patent
LanguageEnglish
French
Published 28.11.2017
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed. La présente invention concerne des composés et des sels pharmaceutiquement acceptables desdits composés, lesdits composés présentant une structure répondant à la formule (I) telle que définie dans la description. L'invention concerne également des compositions pharmaceutiques correspondantes, des méthodes de traitement, des procédés de synthèse et des intermédiaires.
Bibliography:Application Number: CA20132882386